Correlation of response with overall survival (OS) for nivolumab vs everolimus in advanced renal cell carcinoma (aRCC): Results from the phase III CheckMate 025 study Meeting Abstract
| Authors: | Grünwald, V.; Motzer, R. J.; Sharma, P.; Escudier, B.; McDermott, D. F.; George, S.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Plimack, E. R.; Nathan, P.; Tomita, Y.; Zhao, H.; Waxman, I. M.; Hammers, H. J. |
| Abstract Title: | Correlation of response with overall survival (OS) for nivolumab vs everolimus in advanced renal cell carcinoma (aRCC): Results from the phase III CheckMate 025 study |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 39 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2016 Oct 14-18 |
| Meeting Location: | Leipzig, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2016-10-01 |
| Start Page: | 264 |
| End Page: | 265 |
| Language: | English |
| ACCESSION: | WOS:000385691300661 |
| PROVIDER: | wos |
| DOI: | 10.1159/000449050 |
| Notes: | Meeting Abstract: P878 -- Source: Wos |
